Sam Chun Dang Pharm Co Ltd banner
S

Sam Chun Dang Pharm Co Ltd
KOSDAQ:000250

Watchlist Manager
Sam Chun Dang Pharm Co Ltd
KOSDAQ:000250
Watchlist
Price: 411 500 KRW 8.29% Market Closed
Market Cap: ₩9.7T

Sam Chun Dang Pharm Co Ltd's latest stock split occurred on Apr 19, 2002

The company executed a 10-for-1 stock split, meaning that for every share held, investors received 10 new shares.

The adjusted shares began trading on Apr 19, 2002. This was the only stock split in Sam Chun Dang Pharm Co Ltd's history.

Last Splits:
Apr 19, 2002
10-for-1
Pre-Split Price
N/A
Post-Split Price
1 892.1672
Before
After
Last Splits:
Apr 19, 2002
10-for-1

Sam Chun Dang Pharm Co Ltd
Stock Splits History

Sam Chun Dang Pharm Co Ltd Stock Splits Timeline
Apr 19, 2002
Apr 19, 2002
Split 10-for-1
x10
Pre-Split Price
N/A
Post-Split Price
1 892.1672
Before
After

Global
Stock Splits Monitor

Date Company Split Pre-Split Price Post-Split Price
Apr 24, 2026
Medical Data Vision Co Ltd
TSE:3902
2-for-7253607
/3626803.5
1684 1684 JPY N/A
Apr 24, 2026
Metro Mining Ltd
ASX:MMI
1-for-20
/20
0.067 1.34 AUD 1.3 1.3 AUD
Apr 23, 2026
S
Saudee Group Bhd
KLSE:SAUDEE
1-for-10
/10
0.01 0.1 MYR 0.09 0.09 MYR
Apr 23, 2026
Focus Technology Co Ltd
SZSE:002315
1-for-1
x1
44.3999 33.4538 CNY 32 32 CNY
Apr 23, 2026
H
Heritage Distilling Holding Company Inc
NASDAQ:IPST
1-for-20
/20
5.76 5.76 USD 5.5 5.5 USD
Load More

Sam Chun Dang Pharm Co Ltd
Glance View

Market Cap
9.7T KRW
Industry
Pharmaceuticals

Sam Chun Dang Pharm Co Ltd is a quintessential tale of innovation and resilience in the ever-evolving pharmaceutical landscape. Founded in 1943, this South Korean company has steadily crafted its way into becoming a significant player in the generic drug market. Initially focusing on traditional herbal remedies, the company astutely shifted its focus towards the production of generic drugs, capitalizing on the increasing demand for cost-effective alternatives to branded medications. Sam Chun Dang's business model pivots on manufacturing and distributing a wide range of pharmaceutical products, including prescription drugs, over-the-counter medicines, and active pharmaceutical ingredients, catering to both domestic and international markets. The company thrives by meticulously investing in research and development, ensuring a robust pipeline of new generics ready for market entry as patents on branded drugs expire. By emphasizing quality and affordability, Sam Chun Dang Pharm Co Ltd leverages its state-of-the-art manufacturing facilities, accredited by international standards, to maintain a competitive edge. Their profitability stems from not only their comprehensive product lineup but also strategic partnerships and collaborations that enhance their market penetration. Despite operating within a highly competitive and regulated industry, Sam Chun Dang’s commitment to consistent quality and innovation helps them sustain revenue growth and solidify their position as a reputable pharmaceutical provider.

Intrinsic Value
8 992.31 KRW
Overvaluation 98%
Intrinsic Value
Price ₩411 500
S
Back to Top
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett